Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.7650
+0.0238 (3.21%)
At close: Aug 22, 2025, 4:00 PM
0.7750
+0.0100 (1.31%)
After-hours: Aug 22, 2025, 5:59 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.32 million as of August 22, 2025. Its market cap has increased by 36.54% in one year.
Market Cap
3.32M
Enterprise Value
-286.96K
1-Year Change
36.54%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.32M, a decrease of -98.40%. That is a compound annual growth rate of -73.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 3.22M | -67.06% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |